Current pharmacotherapies for obesity-Reference-Cited by-同舟云学术

Current pharmacotherapies for obesity

Published:2017-10 Issue:S1 Volume:29 Page:S43-S52
ISSN:2327-6924
Container-title:Journal of the American Association of Nurse Practitioners
language:en
Short-container-title:

Author:

Golden Angela

Funder

Novo Nordisk

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Nursing

Reference30 articles.

1. Multimorbidity in a prospective cohort: Prevalence and associations with weight loss and health status in severely obese patients;Agborsangaya;Obesity Retrieved,2015

2. Pharmacological management of obesity: An endocrine society clinical practice guideline;Apovian;Journal of Clinical Endocrinology & Metabolism,2015

3. Maintained intentional weight loss reduces cardiovascular outcomes: Results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial;Caterson;Diabetes, Obesity and Metabolism,2012

4. Food and Drug Administration's obesity drug guidance document: A short history;Colman;Circulation,2012

5. Long term maintenance of weight loss with non‐surgical interventions in obese adults: Systematic review and meta‐analyses of randomised controlled trials;Dombrowski;BMJ,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development;DARU Journal of Pharmaceutical Sciences;2024-09-14

2. Ameliorative potentials of ethanol extract of Alchornea cordifolia on some biochemical and physiological parameters in high-fat diet-induced obese Wistar rats;2024-03-21

3. Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit;Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity;2023-11-28

4. Liraglutide 3.0 mg and Mental Health: Can Psychiatric Symptoms Predict Adherence to Therapy? Insights from a clinical audit;2023-01-10

5. Recent advancements in pharmacological strategies to modulate energy balance for combating obesity;RSC Medicinal Chemistry;2023